IL-1 Receptor Family

Citation preview

IL-1 Receptor Family Luke A. J. O'Neill1,* and Steve K. Dower2 1

Department of Biochemistry & Biotechnology, Trinity College Dublin, Dublin, Ireland Division of Molecular & Genetic Medicine, University of Sheffield, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK 2

* corresponding author tel: 353 1 6082439, fax: 353 1 6772400, e-mail: [email protected] DOI: 10.1006/rwcy.2000.02005.

SUMMARY Interleukin-1 (IL-1) is a potent proinflammatory cytokine which induces the expression of immune and inflammatory genes in target cells. Its effects are mediated via the type I IL-1 receptor (IL-1RI), in a complex with the IL-1 receptor accessory protein (IL1R AcP). Both of these proteins are highly homologous but only IL-1R1 is capable of binding ligand. In addition, there is a type II IL-1 receptor (IL-1RII), which does not signal, but which instead is shed from cells, acting as a decoy. Along with these receptors, there is a growing superfamily of proteins which share homologies with IL-1RI. These include receptors that, similar to IL1RI, have immunoglobulin domains extracellularly and a conserved cytosolic sequence. The receptors for IL-18 (formerly termed IL-1RrP) and its accessory protein AcPL, and T1/ST2, whose ligand is still unknown, have these features. In addition there are receptors that, although they have the conserved cytosolic domain, are different extracellularly, having leucine-rich repeats. The founder member here is the Drosophila protein Toll, and the conserved cytosolic domain has as a result been named the Toll±IL-1R (TIR) domain. Other members with leucine-rich repeats extracellularly include six Toll-like receptors (TLRs). LPS from gram-negative bacteria appears to be able to signal using TLR-4, while products from gram-positive bacteria use TLR-2. In addition, a number of plant proteins have been described which are similar to Toll, including N protein from tobacco, L6 protein from flax, and Rpp5 from Arabidopsis, which participate in disease resistence in plants. The final member of the superfamily is MyD88, which is cytosolic and contains a TIR domain and a death

domain. MyD88 is a critical adapter for IL-1R, IL-18R, and TLR-4, and may therefore be the adapter for the entire superfamily. This expanding receptor superfamily therefore represents an ancient signaling system which participates in innate immunity and inflammation.

INTRODUCTION IL-1 is one of the most intensively studied cytokines. This is partly for historical reasons ± IL-1 being one of the first cytokines to be discovered ± but is also because of its pleiotropic effects (Dinarello, 1996). Virtually every cell type responds to IL-1, the major response being to acquire an inflamed phenotype, i.e. the enhanced expression of a range of genes which encode proteins with roles in inflammation and immunity. Current estimates indicate that up to 200 genes change in response to IL-1 in diverse cell types, although this number is bound to increase, given the latest microarray technologies, where thousands of genes can be monitored simultaneously. The IL-1 ligand family comprises three members, IL-1, IL-1 , and the IL-1 receptor antagonist (IL1Ra). The earliest observations in relation to a possible receptor for IL-1 indicated that both IL-1 and IL-1 bound to the same receptor, which had a molecular weight based on crosslinking analysis of 80 kDa (Dower et al., 1986a; Bird and Saklatvala, 1996). IL-1Ra is unique in that it is the only known endogenous receptor antagonist to a cytokine, acting to block binding of either type of IL-1 (Eisenberg et al., 1990). The effects of IL-1 are mediated by the type I IL-1 receptor complex, comprising the type I

1566 Luke A. J. O'Neill and Steve K. Dower receptor (IL-1RI) and its accessory protein, IL-1R AcP, which is unable to bind IL-1 but acts as the second chain in the receptor complex and is essential for signaling (Stylianou et al., 1992; Sims et al., 1993; Greenfeeder et al., 1995). Apart from these two proteins, a steadily growing superfamily of homologous receptors has become Figure 1 The major members of the IL-1 receptor/Toll-like receptor superfamily. All members contain a conserved cytosolic region termed the TIR domain (Toll±IL-1 receptor domain). The superfamily can be divided into two subgroups. The immunoglobulin subgroup members all contain immunoglobulin domains extracellularly and include receptors and accessory proteins for IL-1 and IL-18. Several members have no known ligand (e.g., T1/ST2, IL-1RAPL). The leucine-rich repeat subgroup members have leucine-rich repeats and include the signaling receptors for LPS (TLR4) and various plant proteins. Many of the members of this subgroup also have no known ligands. Finally, MyD88 is exclusively cytosolic and is a signaling adapter for IL-1RI, IL-18R, TLR-2, and TLR-4, if not the entire family.

apparent. These are shown in Figure 1. The superfamily includes the adapter protein MyD88, another essential component in the receptor complex (Wesche et al., 1997a; Burns et al., 1998), linking the receptor via a probable homotypic interaction to downstream signaling components, which include two IL-1 receptor associated kinases, IRAK and IRAK-2 (Martin et al., 1994; Cao et al., 1996; Muzio et al., 1997). Other members include the type II IL-1 receptor (which is shed from cells and acts as a decoy) (McMahon et al., 1991; Colotta et al., 1993), the IL-18 receptor complex (comprising IL-1Rrp1 (Parnet et al., 1996; Torigoe et al., 1997) and AcPL (Born et al., 1998)) and a number of receptors homologous to the Drosophila protein Toll, and termed TLRs (Rock et al., 1998; Takeuchi et al., 1999). It appears that TLRs may act as receptors for bacterial products such as LPS, TLR-4 being a strong contender for the much-sought-after LPS signaling receptor (Poltorak et al., 1998; Chow et al., 1999). In addition, there are several plant members of the family, all involved in disease resistance in plants (Hammond-Kosack and Jones, 1996). This growing list of proteins, all of which share a common signaling sequence, is intriguing, and suggests that the IL-1 receptor system is very ancient and is used in signaling in a wide range of species, mainly in the context of defense and response to injury. The importance of IL-1 and its receptor system in disease is underscored by the recent clinical efficacy of IL-1Ra in rheumatoid arthritis (Bresnihan et al., 1998). The rapidly expanding list of receptors in the family represents a challenge common to all other branches of cytokine biology at present, given the deluge of information emerging from genome sequencing. The common theme in the IL-1 system, however, is that of inflammation and defense, the signaling region of the family obviously representing a highly efficient machine which, when triggered, leads to the induction of a bank of genes important for the elimination of infection and subsequent repair. The overactivation of this system appears to contribute to the pathogenesis of inflammatory diseases, for example, rheumatoid arthritis. The relationship of the IL-1/TLR family to innate and acquired immunity is also discussed in the chapter on Proinflammatory Cytokines.

DEFINING THE IL-1R/TLR FAMILY Based on sequence homologies, it is possible to divide the IL-1R/TLR superfamily into two groups, as shown in Figure 1. The first consists of the founder

IL-1 Receptor Family 1567 member of the entire family (being the first one whose gene sequence was determined), IL-1RI (Sims et al., 1988). The members of this group all contain extracellular (immunoglobulin domains) and intracellular (the IL-1R/TLR signaling domain, also termed the TIR domain) homologies. Apart from IL-1RI, this group contains the aforementioned IL-1R AcP (Greenfeeder et al., 1995), IL-1RII (McMahon et al., 1991) and its vaccinia virus homolog B15R (Alcami and Smith, 1992) (which are included here because of their three immunoglobulin domains), and IL-18R (Torigoe et al., 1997) and its accessory protein AcPL (accessory protein-like) (Born et al., 1998). In addition, there is IL-1RrP2 (Lovenberg et al., 1996), T1/ ST2 (Mitcham et al., 1996), single Ig IL-1R-related molecule (SIGIRR) (Thomassen et al., 1999), and IL-1 receptor accessory protein-like (IL-1RAPL) (Carrie et al., 1999), whose ligands have yet to be discovered. SIGIRR, as its name suggests, only contains a single immunoglobulin-like domain, unlike the other group members. IL-1RAPL is expressed in the hippocampus, and when mutated it is responsible for one form of X-linked mental retardation (Carrie et al., 1999). It may be a novel accessory protein. The members of the second group also have the TIR domain, but are quite different extracellularly, having a series of leucine-rich repeats. The founder member if this group is Toll, as mentioned above (Hashimoto et al., 1988; Gay and Keith, 1991). There are three further Drosophila members, termed 18Wheeler (Eldon et al., 1994), MstProx (Sims and Dower, 1994), and Tehao. The putative ligand for Toll is Spatzle (Morisato and Anderson, 1994), with ligands for the other two proteins as yet unknown. The six mammalian TLRs so far described are also in this subgroup (Rock et al., 1998; Takeuchi et al., 1999), as are the plant proteins (Whitham et al., 1994; Hammond-Kozack and Jones, 1996; Parker et al., 1997), which, although exclusively cytosolic, have leucine-rich repeats and are therefore more closely related to Toll than to IL-1RI. The final protein in the family, MyD88, is an exclusively cytosolic protein which does not belong to either group, since it only has the region of homology which defines the entire family (i.e. the TIR domain) (Wesche et al., 1997a; Burns et al., 1998). The degree of sequence similarity in each of these groups is quite striking. Figure 2a±c shows alignments of the superfamily, with Table 1 giving the GenBank accession numbers of all of the sequences aligned. Figure 2a demonstrates an alignment of the extracellular regions of superfamily members in the immunoglobulin subgroup. From the consensus sequence, the conserved cysteines and bulky hydrophobic tryptophans, characteristic of immunoglobulin domains,

can be seen. Figure 2b demonstrates an alignment of members in the leucine-rich repeat subgroup. From its consensus sequence it can seen that the conserved residues are mainly leucines. Decorin and platelet protein 5 are included as examples of other leucinerich repeat proteins which will be detected in a BLAST search using TLRs. Figure 2c demonstrates an alignment of the TIR domain in all family members. The degree of cross-species ± and, indeed, cross-kingdom ± similarity is remarkable. Included in this alignment are sequences from human, mouse, rat, hamster, Drosophila melanogaster, Caenorhabditis elegans and, particularly surprisingly, a protein from the bacterium Streptomyces coelicolor. Such conservation supports the view that the TIR domain is very ancient, and may have arisen prior to the divergence of prokaryotes from eukaryotes. As can been seen from this alignment, there are three boxes within the sequences which align, termed box 1, box 2, and box 3. In 1992, prior to the discovery of most of the superfamily members, biochemical data on the residues important for receptor function were described (Heguy et al., 1992). Arg431 in box 2, and Phe 513 and Trp514 in box 3 of IL-1RI are essential for receptor function (Heguy et al., 1992). In addition, more recently it was shown that Pro712 in Box2 of TLR-4 was required for signaling since, in the LPSresistent C3H/HeJ mouse, this amino acid is mutated. Since TLR-4 is the signaling receptor for LPS, it can be inferred that this mutation leads to a defective receptor (Poltarak et al., 1998). These features will be discussed below. As yet, the structure of the TIR domain has not been elucidated, either from data obtained by X-ray crystallography or modeling.

IL-1RI Prior to the cloning of IL-1RI, Scatchard analysis using radiolabeled IL-1 revealed a number of interesting features. First, the receptor had a high affinity for its ligands, with Kd values in the subnanomolar range (Dower et al., 1986b). Second, IL-1 was active on cells far below the Kd of the putative receptor, with cells being responsive with receptors numbering less than 10 per cell (Dower et al., 1986b). This implied that a large degree of amplification must occur during signaling. Finally, it appeared that IL-1, once bound to its receptor, was rapidly internalized, the receptor possibly acting simply as an internalization vector (Bird and Saklatvala, 1987). The gene for IL-1RI was cloned in 1988 and was identified as the 80 kDa protein found by crosslinking

1568 Luke A. J. O'Neill and Steve K. Dower

Figure 2 Sequence alignments for the IL-1 receptor/Toll-like receptor superfamily. Following database searches, sequence alignments were performed on members of the superfamily. (a) Alignment of the extracellular domains of the immunoglobulin subgroup of the superfamily. Twelve members are shown, including the predicted amino acid sequence of the vaccinia gene B15R, which is homologous to IL-1RII. The consensus sequence indicates key conserved cysteines characteristic of immunoglobulin domains. (b) Alignment of the extracellular domains of the leucine-rich repeat subgroup of the superfamily. Thirteen members are shown, including the human Toll-like receptors and rp105, which is homologous to the family extracellularly. Conserved leucines are indicated in the consensus sequence. (c) Alignment of the TIR domain of the superfamily. Members of both subgroups are included. Three conserved boxes are indicated, along with a consensus sequence. The function of these boxes is as yet unknown, although mutations in amino acids in boxes 2 and 3 abolish receptor function (see text for details). Family members from C. elegans and S. coelicolor, which have not been described before, are also shown.

Figure 2 (Continued )

IL-1 Receptor Family 1569

Figure 2 (Continued )

1570 Luke A. J. O'Neill and Steve K. Dower

Figure 2 (Continued )

IL-1 Receptor Family 1571

Figure 2 (Continued )

1572 Luke A. J. O'Neill and Steve K. Dower

Figure 2

(Continued )

IL-1 Receptor Family 1573

1574 Luke A. J. O'Neill and Steve K. Dower

Table 1 Species and GenBank accession numbers for sequences used in the alignments shown in Figure 2 Sequence name

Species

Accession number

huIL18Racp

Homo sapiens

AAC72196

muIL18RacP

Mus musculus

AAC72197

huIL18R

Homo sapiens

U43672

muIL18R

Mus musculus

U43673

muil1racp

Mus musculus

U43673

muil1r1

Mus musculus

M20658

ratil1r

Rattus norvegicus

M95578

huil1r1

Homo sapiens

X16896

chil1r1

Gallus gallus

M81846

ratil1rrp

Rattus norvegicus

U49066

ratst2

Rattus norvegicus

U04317

humyd88

Homo sapiens

U84408

mumyd88

Mus musculus

U84409

hutlr3

Homo sapiens

U88879

hutlr5

Homo sapiens

AF051151

hutlr1

Homo sapiens

D13637

hutlr6

Homo sapiens

NM_006068

hutlr2

Homo sapiens

U88878

hutlr4

Homo sapiens

U88880

drotoll

Drosphila melanogaster

P08953

drotoll2

Drosphila melanogaster

AF140019

dromstprox

Drosphila melanogaster

U42425

wheeler

Drosphila melanogaster

L23171

arabrpp1

Arabdopsis thaliana

AF098963

arabrrp5

Arabdopsis thaliana

CAB46048

ngene

Nicotiana glutinosa

A54810

L6

Linum usitatissimum

AAD25976

CelegTran

Caenorhabditis elegans

Z49936

Strepprot

Streptomyces coelicolor

AL021411

CelegEST

Caenorhabditis elegans

D70209

B15R

Vaccinia virus

A19577

HuIL1R2

Homo sapiens

U64094

hupgp5

Homo sapiens

Z23091

hudecorin

Homo sapiens

P07585

rp105

Homo sapiens

D83597

analysis (Sims et al., 1988). Its sequence revealed three immunoglobulin domains extracellularly. The cytosolic region was unique at that time, and therefore gave no clues as to a possible signal transduction

mechanism. In 1992, site-directed mutagenesis studies revealed that six amino acids, conserved in the sequences of those receptors which had been cloned (human, mouse, and chicken IL-1RI and Toll) were

IL-1 Receptor Family 1575 found to be essential for signaling, namely Arg431, Lys515, Arg518, Phe513, Trp514, and Tyr519 (Heguy et al., 1992). In addition, Pro521 was also required for maximal signaling capacity. Phe513 and Trp514 are in the conserved box 3 in the TIR domain of IL-1RI, as described above and shown in Figure 2c. The precise role of each of these amino acids is still undetermined. Presumably they are required for correct recognition of the signaling domain by signaling proteins. Given that they also occur in IL-1R AcP and MyD88, it is possible that the homotypic association of this region is required for signaling. Such a trimerization (i.e. between TIR domains in IL-1RI, IL-1R AcP, and MyD88) also occurs in the p55 TNF receptor system, in which trimeric TNF brings together three death domains in each p55 TNFR. One amino acid, Tyr479, has been suggested to interact directly with a signaling protein. It has been suggested that p85 from PI-3 kinase associates with this Tyr, when phosphorylated, thereby recruiting p110, the catalytic subunit of PI-3 kinase, to the membrane (Marmiroli et al., 1998). Tyr479 occurs in a motif recognized by p85, Tyr-Glu-X-Met. Another group has recently shown that p85 associates with IL-1R AcP rather than IL-1RI (Sizemore et al., 1999). IL-1R AcP does not, however, contain a homologous Tyr. In that study the role of PI-3 kinase was to induce the phosphorylation of the p65 subunit of the transcription factor NFB. The importance of IL-1RI for biological effects of IL-1 can be seen from a number of studies. Antibodies to the IL-1RI have been shown to block IL-1 responses in several cell systems. In addition, IL1RI knockout mice have revealed that this receptor mediates the induction of such IL-1 responses as increased IL-6 production and fever (Labow et al., 1997). In addition, the acute-phase response, delayedtype hypersensitivity, and the ability to combat infection by Listeria monocytogenes were all impaired (Labow et al., 1997). There was also an enhanced TH2-like response in such mice, which was suggested to be due to enhanced IL-4 and IL-10 production, implying that IL-1 limits the production of these cytokines. These results all indicate the importance of IL-1RI for inflammation and infection. There has also been progress on the structural basis for IL-1RI recognition by IL-1. In 1997 the crystal structures of IL-1RI in a complex with IL-1 or IL-1Ra were solved to 2.7 AÊ resolution (Schreuder et al., 1997; Vigers et al., 1997). The structures revealed that immunoglobulin domains 1 and 2 are tightly linked, but that domain 3 is separate and connected by a flexible linker. IL-1 contacts the receptor via two regions, one of these interacting with the first two domains and the other with domain 3. The binding of

IL-1 actually induces a conformational change, which results in domain 3 moving, such that the receptor actually wraps around the ligand (Vigers et al., 1997). IL-1Ra, unlike IL-1 , does not induce a movement in domain 3 (Schreuder et al., 1997). This may be because IL-1Ra only contacts IL-1RI at domains 1 and 2. Such a movement may allow interaction between IL-1RI and IL-1R AcP, which then triggers the signal. Using antibodies, two hydrophilic domains have been identified in IL-1R AcP, which are critical for signaling and hence possible interaction with IL-1RI (Yoon and Dinarello, 1998). A full account of the molecular changes which occur upon binding IL-1 in IL-1RI and IL-1R AcP extracellularly, and indeed intracellularly, will await the full elucidation of all the structures involved, both in the absence and presence of ligand.

IL-1RII Crosslinking analysis had also revealed that on certain cell types, e.g. 70Z/3 pre-B cells, a second complex could be detected with a molecular weight of about 60 kDa, which could not be immunoprecipitated with anti-IL-1RI antibodies (Matsushima et al., 1986; Horuk et al., 1987). This was subsequently cloned and named IL-1RII (McMahon et al., 1991). Extracellularly, it was highly homologous to IL-1RI, having three immunoglobulin domains. Intracellularly, however, it proved very different, having only a short cytoplasmic tail of 29 amino acids. In terms of expression, the expression of IL-1RII was more restricted than that of IL-1RI, being highly expressed on lymphoid and myeloid cells (McMahon et al., 1991). Certain cell types express both receptors, and even in cells where IL-1RII appears to predominate, low levels of IL-1RI can be detected (Stylianou et al., 1992). Clear evidence then emerged that IL-1RI was responsible for generating the signal, with IL-1RII being unable to signal (Stylianou et al., 1992; Sims et al., 1993). Finally, it was shown that IL-1RII is actually shed from cells and acts as a decoy receptor, preventing IL-1 from binding to IL-1RI (Colotta et al., 1993). This provides another means (along with IL-1Ra) of limiting IL-1 action. The shedding of IL-1RII from neutrophils can be induced by glucocorticoids and IL-4, which may form part of their anti-inflammatory effects. Another interesting feature in relation to inhibitory effects of IL-1RII is its ability to interact with and thereby limit the availabilty of IL-1R AcP (Lang et al., 1998). This may prevent IL-1RI from recruiting IL1R AcP, which would inhibit IL-1 signaling. Also of

1576 Luke A. J. O'Neill and Steve K. Dower note is the observation that IL-1RII has a very low affinity for IL-1Ra (Symons et al., 1995), which is consistent with the role of both proteins as inhibitors of IL-1 binding to IL-1RI. A search of the database with IL-1RII revealed a homolog in several viruses of the pox family, most notably vaccinia virus, whose B15R encodes a protein very similar to IL-1RII (Alcami and Smith, 1992; Spriggs et al., 1992), and which, if deleted from the vaccinia genome, gives rise to a much more virulent virus. This indicates that the role of B15R in vaccinia is to limit the damage caused by the overproduction of IL-1 during infection. Of particular note was the observation that virus lacking B15R is much more pyrogenic than wild-type virus (Alcami and Smith, 1996), providing further proof that IL-1 is a key pyrogenic cytokine, and in the case of viral infection probably the most important endogenous pyrogen.

both have a TIR domain, there are differences in sequence, which might lead to the recruitment of different proteins during signaling. Indeed, it has been suggested from immunoprecipitation studies that the IL-1 receptor-associated kinase (IRAK) is recruited via IL-1R AcP, with IRAK-2 being recruited to IL1RI (Huang et al., 1997; Muzio et al., 1997; Volpe et al., 1997). Both also appear to be recruited via MyD88 (Muzio et al., 1997; Wesche et al., 1997a; Burns et al., 1998). Whether IL-1R AcP will have a subtly different role from IL-1RI in signaling will await further clarification. A plausible scenario is that the interaction between IL-1RI and IL-1R AcP creates a novel surface which allows MyD88 to be recruited in a homotypic manner.

IL-1R ACCESSORY PROTEIN

In 1996 a homology-based search of the database uncovered two additional members of the IL-1R family, which were termed IL-1 receptor-related proteins 1 and 2 (IL-1Rrp1 and 2) (Lovenberg et al., 1996; Parnet et al., 1996). At the time these had no known ligands but chimeric receptors comprising extracellular IL-1RI and intracellular IL-1Rrp1 could signal in response to IL-1 (Parnet et al., 1996). It was subsequently shown that IL-1Rrp1 is the receptor for IL-18 (Torigoe et al., 1997), a cytokine first described as IFN -inducing factor, which had a strikingly similar structure to IL-1 (Bazan et al., 1996). Similar structural features are therefore likely to form the basis for interactions between IL-1/IL-1RI and IL-18/ IL-1Rrp1. IL-18R has replaced IL-1Rrp1 as the name of the IL-18 receptor. Similarities between the two cytokine systems also extend to signaling pathways, with IL-18 activating identical pathways to IL-1 (Kojima et al., 1998). In addition, MyD88 knockout mice are unresponsive to both IL-1 and IL-18 (Adachi et al., 1998), confirming the importance of MyD88 as the key adapter for TIR domain-containing receptors. Cells prepared from IRAK knockout mice are similarly unresponsive to IL-1 or IL-18 (Kanakaraj et al., 1999), further emphasizing the importance of IRAK in signaling by the family. The lack of IRAK could obviously not be compensated for by IRAK-2, or indeed the recently described third IRAK, termed IRAKm, which appears to be exclusively expressed in myeloid cells (Wesche et al., 1999). IL-18R is detectable in lung, spleen, heart, testis, peripheral blood T cells, and NK cells (Torigoe et al., 1997). It is notably absent from brain, although again this may be a detection problem. IL-18R is

The discovery of IL-1RI and IL-1RII appears to account for all of the binding capacity of cells for IL-1. Early experiments also indicated that IL-1RI alone appeared capable of driving IL-1 signals (Curtis et al., 1989). This was based on the reconstitution of signaling in Chinese hamster ovary cells by transfection of IL-1RI. It was then found that an antibody which did not recognize IL-1RI or IL-1RII was able to block IL-1 signals in cells without affecting IL-1 binding (Greenfeeder et al., 1995). The target for this antibody was found to be IL-1R AcP. As mentioned above, this is the second chain of the IL-1R complex, which does not bind IL-1 but which is essential for signaling (Greenfeeder et al., 1995; Wesche et al., 1997b). IL-1R AcP is widely expressed and on the whole its expression correlates with that for IL-1RI. The exception to this is in brain, where in rat they have been found not to colocalize (Liu et al., 1996), although whether this is a problem with different detection sensitivities requires further analysis. Apart from its role in signaling, IL-1R AcP also appears to increase the affinity of IL-1RI for ligand by about 5-fold (Greenfeeder et al., 1995). In spite of this, it is still not clear whether IL-1RI and IL-1R AcP are in a complex prior to the addition of ligand. As discussed above, IL-1 may cause a conformational change in IL-1RI which recruits IL-1R AcP to the complex. Another more likely scenario is that the addition of ligand increases the affinity of IL-1RI for IL-1R AcP, which prior to ligand is in a low-affinity complex. It is also unclear whether IL-1RI and IL-1R AcP interact with the same signaling components. Even though

IL-18 RECEPTOR COMPLEX

IL-1 Receptor Family 1577 particularly associated with natural killer cell and TH1 cell activation. An intriguing observation concerns the relative roles of IL-1 and IL-18 in helper T cell function. IL-18 appears preferentially to augment TH1 cell effector responses, whereas IL-1, although capable of potentiating IL-12-induced TH1 cell development, is also capable of augmenting TH2 cell function (Robinson et al., 1997). This latter result is inconsistent with the data from IL-1RI knockout mice, which have an enhanced TH2 response (Labow et al., 1997). This is discussed further below. A role for IL-18 in TH2 cell function is consistent with the lack of IL-18R expression on TH2 cells (Xu et al., 1998). A role for IL-18R in TH1 cells is borne out from studies with IL-18R knockout mice (Hoshino et al., 1999a). These mice had TH1 cells which were unresponsive to IL-18 and defective cytolytic responses in their NK cells. In addition, TH1 cell development was impaired. Similar phenotypes were observed in MyD88 and IRAK knockout mice, which again points to the importance of these signaling proteins in IL-18R action. In 1998 the cloning of the accessory protein for IL-18R was reported (Born et al., 1988). This was again discovered from a homology search and, because of its homology particularly with the IL-1R AcP, was named AcPL, for accessory protein-like. Its expression appears to be more restricted than IL18R, in that it is not detectable in heart or testis by northern blot analysis. It seems highly likely at this stage that AcPL will function in an exactly analogous manner to IL-1R AcP in IL-1 signaling.

T1/ST2 In 1989 two separate groups reported on the cloning of what was then the only other protein with a similar sequence to IL-1RI (Klemenz et al., 1989; Tominaga, 1989). This was named T1 or ST2, and was cloned as a delayed early-response gene induced in response to proliferative signals. It was characterized as a secreted protein whose sequence suggested a soluble IL-1 receptor, with a transmembrane form subsequently being characterized (Yanagisawa et al., 1993). The homology with IL-1RI in the transmembrane form extends throughout the molecule: T1/ST2 contains immunoglobulin domains extracellularly and the TIR domain intracellularly. Soluble and membrane versions are expressed in different tissues. This is because different promoters lead to different polyadenylation sites and from there to different forms of mRNA (Bergers et al., 1994). The soluble form is mainly produced by fibroblasts and possibly mast cells,

whereas the membrane-bound form is predominantly expressed on hematopoietic cells (Bergers et al., 1994). However, it has also been suggested that in hematopoietic cells, transmembrane T1/ST2 is expressed constitutively, while the soluble form is induced upon stimulation with proinflammatory agents, including IL-1. Soluble T1/ST2 is in fact strongly induced during inflammation in vivo (Kumar et al., 1997). A model for the roles of soluble and membrane-bound T1/ST2 has been proposed whereby the putative ligand when bound to the receptor prevents proliferation, with soluble receptor acting to block this effect (Gayle et al., 1996). This may explain the high levels of soluble T1/ST2 correlating with proliferation. The ligand for T1/ST2 has yet to be found. A putative ligand was described in 1996 which could bind T1/ST2 (Gayle et al., 1996). This ligand was unrelated to IL-1 and could not generate a signal. The TIR domain in T1/ST2 is capable of signaling, as demonstrated in studies with chimeras between extracellular IL-1RI and intracellular T1/ST2 (Mitcham et al., 1996). Recently, a role for T1/ST2 in TH2 cell function has been suggested. Differential display analysis of TH1 or TH2 cells revealed T1/ST2 to be strongly expressed in TH2 cells (Lohning et al., 1988). Its expression on TH2 cells was independent of IL-4, IL-5, or IL-10, making it the only TH2 marker that is IL-4-independent. T1/ST2 was found to play a critical role in TH2 cell function in that a neutralizing antibody to T1/ST2 attenuated TH2-driven responses in vivo. The role of soluble T1/ST2 may therefore be to limit TH2 responses. The uncovering of the ligand for T1/ST2 on TH1/TH2 will therefore be of great significance for TH1/TH2 biology (see chapter on TH1/TH2 Interleukins). Two reports have recently appeared describing T1/ST2-deficient transgenic mice. Confusingly, one report showed no impairment in TH2 cell development or function (Hoshino et al., 1999b), while the other showed impaired TH2 cell effector function (Townsend et al., 2000). These opposing results are unexplained at present.

IL-1RI, IL-18R, AND T1/ST2 IN TH1 AND TH2 CELL FUNCTION From studies on T1/ST2, IL-18R, and IL-1R it is clear that these members of the IL-1R/TLR family have divergent roles in T helper subtype activation. From studies into the development of TH1 or TH2 responses it can be inferred that IL-1RI, IL-18R, and

1578 Luke A. J. O'Neill and Steve K. Dower Figure 3 The signaling pathway to NFB activated by IL-1 in mammalian cells, and that to Dorsal activated by Spatzle in Drosophila melanogaster is highly homologous. The ligands in each case (IL-1 and Spatzle) are very different, since the extracellular domains of the receptors to which they bind differ. The cytosolic regions of the receptors have TIR domains, however. In spite of this homology, the known adapters utilized differ, in that MyD88 is the adapter for IL-1RI, while that for Toll is Tube. A mammalian homolog of Tube has not been described. IL-1 receptor-associated kinase (IRAK) is highly homologous to Pelle, however, with Cactus being an I-B homolog and Dorsal, similar to p50 and p65 in mammals, being a Rel family member. The identity of the proteins linking Pelle to phosphorylation of cactus is not known. The pathway in Drosophila shown is involved in the establishment of dorsoventral polarity. In adult flies a similar pathway is used in response to infection, with Dif, another Rel family member, being involved. Spatzle

IL-1 IL-1RI

Toll

IL-1RAcP

MyD88

Tube IRAK

Pelle

TRAF-6

?

TAK-1

TAB-1

?

NIK

?

IKKs

? Cactus

I-κB p65

p50

dorsal dorsal

T1/ST2 are expressed on TH0 cells. IL-1 acts to potentiate IL-12-driven development of TH1 cells (Robinson et al., 1997). IL-18R but not IL-1R is expressed on TH1 cells, where IL-18 acts to promote TH1 responses in combination with IL-12. IL-1RI on the other hand is expressed on TH2 cells where it induces IL-4 production and proliferation. T1/ST2, however, is only expressed on TH2 cells and is required for TH2 cell function (Lohning et al., 1998). It therefore appears that IL-1 can affect both cell types, with IL-18 affecting TH1 cells and the as-yet undiscovered ligand for T1/ST2 affecting TH2 cells. Such observations are in part based on certain strains of mice and a definitive account of this process in humans is as yet lacking.

Furthermore, studies with transgenic mice indicate that the role of IL-1 is to promote TH1 responses in spite of its in vitro effect on TH2 cells (Labow et al., 1997). In addition, T1/ST2 signaling would be expected to be impaired in MyD88 and IRAK knockout mice. TH1 responses are impaired in such mice but the status of TH2 responses was not determined (Adachi et al., 1998; Kanakaraj et al., 1999). It would be of interest to determine such responses, which, if impaired, could be explained in terms of a lack of T1/ST2 signaling. The fine balance of IL-1, IL-18, and the T1/ST2 ligand may, therefore, have a key role in driving TH1 or TH2 responses (see chapter on TH1/TH2 Interleukins).

TOLL Subsequent to T1/ST2 being described as a homolog of IL-1R, an important homology was described in 1991 between the Drosophila melanogaster protein Toll and IL-1RI (Gay and Keith, 1991). This represented the first description of the TIR domain, although the term TIR has only recently been coined. The homology in the cytosolic regions of Toll and IL1R defines the receptor family, as shown in Figure 1 and Figure 3. Extracellularly, Toll is unlike IL-1RI, in that it does not have immunoglobulin domains. Instead, Toll has leucine-rich repeats (Hashimoto et al., 1988). As a result, the ligand for Toll is quite different: it is a protein termed Spatzle (Morisato and Anderson, 1994), although direct binding of Spatzle to Toll has not been described. Spatzle has a cysteine knot structure, which also occurs in members of the NGF family (Mizuguchi et al., 1998). In addition, the structure of Toll has been modeled and, intriguingly, it resembles platelet glycoprotein 1b (Keith and Gay, 1990), the receptor for von Willebrand factor. In a further similarity, Spatzle, like von Willebrand factor, is generated as a result of a protease cascade, activated in Drosophila during development. Toll was first described as a maternal-effect gene involved in the development of dorsoventral polarity in the developing Drosophila embryo (Hashimoto et al., 1988). The homology between Toll and IL-1RI was particularly intriguing given the target for both pathways (reviewed in O'Neill and Green, 1998). The homologs which occur in both pathways are shown in Figure 3. Toll activates two proteins, termed Tube and Pelle, which in turn lead to the release of a protein cactus from the transcription factor Dorsal. Dorsal is the Drosophila homolog of NFB, while cactus is the IB homolog. Given that the NFB activation is central to IL-1 action, the TIR domain may have evolved to activate NFB. Also of note is

IL-1 Receptor Family 1579 the homology between IRAK and Pelle, pointing to further conservation in both pathways. A homolog of Tube has not yet been found and it is possible that MyD88 acts as a functional homolog in mammals. In adult Drosophila Toll has an additional role in the response to infection. Here, Toll activates another NFB family member, Dif, which regulates the expression of antifungal peptides such as drosomycin (Lemaitre et al., 1997; Meng et al., 1999). It therefore appeared that the Toll and IL-1 systems were conserved across evolution, being activated during infection. This view is further strengthened by the discovery of a human Toll-like receptor, described below.

18-Wheeler, MstProx, and Tehao Three further proteins homologous to Toll have been described in Drosophila: 18-Wheeler, MstProx, and Tehao (Eldon et al., 1994; Sims and Dower, 1994). 18-Wheeler is again involved in development but in the adult is also involved in infection, inducing the production of antibacterial peptides such as attacin, again via the activation of Dif (Williams et al., 1998). This is a potentially interesting difference in that Toll responds to fungal pathogens while 18-Wheeler responds to bacteria (Lemaitre et al., 1997; Williams et al., 1997). Such subtlety may also be apparent in the mammalian TLRs, described below. The role of MstProx and Tehao are as yet unknown. The fact that similar systems are being used in development and immunity possibly indicates the efficiency of this signaling system in the regulation of gene expression.

also inflammatory cytokine production (including IL-1) when expressed as a fusion protein with CD2, which targeted it to the membrane (Medzhitov et al., 1997). These responses are part of the initial innate response to infection. It therefore appeared that the TLR family, using the TIR domain to signal, was a key participant in innate immunity and therefore inflammation. There are differences between the expression patterns of the TLRs (Rock et al., 1998; Takeuchi et al., 1999). TLR-1 is ubiquitously expressed and at a higher level compared to other TLRs. TLR-2 is expressed in brain, heart, muscle, and lung. TLR-3 is expressed in a similar pattern to TLR-2, but with high expression in the pancreas and placenta. In contrast, TLR-4 and TLR-5 are less well-expressed, with placenta and peripheral blood leukocytes showing high-level expression for TLR-4, and ovary and monocytes highly expressing TLR-5. TLR-6 is expressed in spleen, thymus, ovary, and lung (Takeuchi et al., 1999). In addition, certain TLRs have different-length mRNA transcripts in certain tissues, indicating further complexity (Rock et al., 1998). A protein termed RP105 can also be included in the TLR subfamily. This was described in 1995 ± before the TLR family was described ± and was shown to be homologous to Toll extracellularly (Miyake et al., 1995). It has a short cytoplasmic sequence lacking the TIR domain. It is expressed predominantly on B cells and when crosslinked drives proliferation (Chan et al., 1998).

Human Toll-like receptors

TLR-2 and TLR-4 as signaling receptors for bacterial products

In 1998, five proteins were described in humans which were homologs of Toll (Rock et al., 1998). Similar to IL-1RI, they all had conserved cytosolic regions, but extracellularly they resembled Toll, having leucinerich repeats. They were termed human TLRs 1±5. More recently, a sixth TLR, termed TLR-6, has been described (Takeuchi et al., 1999). The sequence of TLR-1 had been described previously and termed rsc786 (Sims and Dower, 1994). In addition, at virtually the same time a human Toll (termed hToll) had been described, which was identical to TLR-4 (Medzhitov et al., 1997). The description of this family and its homology to Toll indicated that TLRs might be important participants in innate immunity since it had long been postulated that human homologs of proteins involved in defense in lower organisms would be found. TLR-4 was shown to be a potent upregulator of B7.1 expression in T cells, and

The most immediate question which arises concerning TLRs is the nature of the ligands which bind them. The work on TLR-4 that demonstrated that it could signal, involved expressing it as a membrane-localized fusion protein (Medzhitov et al., 1997). The breakthrough on the identity of a possible ligand came from work on gram-negative LPS. In 1998 it was demonstrated by two separate groups that in human cells TLR-2 was required for LPS signaling (Kirschning et al., 1998; Yang et al., 1998). LPS had been known for some time to induce signals very similar to IL-1, and there had been suspicions that the effect of LPS may have been mediated via IL-1 production. It was also known that CD14 was required for LPS action (Wright et al., 1990), although since CD14 was a glycophosphatidylinositol-anchored protein, it was suspected that a second chain was needed to generate the signal. This second chain was

1580 Luke A. J. O'Neill and Steve K. Dower postulated to be TLR-2 since it was possible fully to reconstitute LPS responses in 293 cells cotransfected with CD14 and TLR-2 (Kirschning et al., 1998; Yang et al., 1998). There is also evidence that TLR-4 is required for LPS signaling. This has come from studies into LPSresistant mice. The genetic mutation in the C3H/HeJ mouse has long been sought after and was found to be in the gene for TLR-4 (Poltarok et al., 1998). A single point mutation at Pro712 in box 2 of the TIR domain was found in the TLR-4 gene in these mice, which rendered TLR-4 unable to signal. Similarly, in the C57BL/10ScCr mouse, which is also LPS-resistant, there is a null mutation in the TLR-4 gene (Poltorak et al., 1998). It therefore appears that TLR-2 and/or TLR-4 are signaling receptors for LPS. This further expands the utility of the IL-1/TLR family of proteins, and clearly emphasizes their importance for innate immunity. There are some unanswered questions in relation to LPS and the TLRs. TLR-2 is intact in both C3H/HeJ and C57BL/10ScCr mice and yet they are still unresponsive to LPS (Poltorak et al., 1998). Could there be differences between humans and mice in relation to which TLR is responsible for LPS action?. It has been known for some time that different animals respond differently to LPS mimetics, with certain lipid A analogs acting as LPS antagonists in humans but agonists in mice and hamsters (Golenbock et al., 1991). This could be due to species differences in terms of which TLR is responding to LPS. Alternatively, perhaps a dimer of TLR-2 and -4 provides the optimal signal transducer for LPS. It has also been shown recently that Chinese hamster ovary cells are responsive to LPS when transfected with CD14, but that TLR-2 is not required for this response since the TLR-2 gene has a deletion which results in a protein without a cytosolic region (Heine et al., 1999); indeed, this feature is also present in the hamster genome. TLR-4 may therefore be more important in hamsters, as in mice. Further complexity has recently been indicated, demonstrating that another protein, termed MD-2, is required for TLR-4 responsiveness, indicating that all of the components required for LPS responses may not have been uncovered (Shimazu et al., 1999). Another question concerns whether LPS binds to either TLR and the precise role of CD14. If TLRs are functionally analogous to Toll, they might be expected to have endogenous ligands, although no Spatzle homolog, if indeed this is the ligand for Toll, has yet been found in mammals. It is possible that they might function as adhesion molecules, as has been suggested for Toll (Keith and Gay, 1990), possibly aggregating homo- or heterotypically. Another

Figure 4 IL-1, IL-18, and LPS: receptors and signaling. The IL-1 receptor complex comprises IL-1RI and IL-1R AcP, with IL-1RI undergoing a conformational change upon ligand binding. A similar conformational change may occur in IL-18R, which has its own accessory protein (AcPL or IL-18RAcP). LPS acts via LBP, CD14, MD-2, and TLR-4, with TLR-4 acting as the signaling component. The TIR domains (hatched box), probably through homotypic interactions, recruit MyD88 via its TIR domain, which then mediates the signals common to all three stimuli via IRAK, IRAK-2, and TRAF-6. This leads to the activation of NFB and the MAP kinases p38, JNK, or p42/p44, ultimately driving proinflammatory gene expression. The signaling pathways are reviewed by O'Neill and Greene (1998). The role of NFB-inducing kinase (NIK) has recently been disputed (Shinkura et al., 1999).

LPS IL-1β IL-1RAcP

LBP

IL18 IL-1RI

IL-18RAcP

IL-18R

TLR2/4

MD2

CD14

MyD88 IRAK IRAK2 TRAF6 TAK1 NIK

p38

JNK

p42 /p44

IKK complex

question concerns specificity in the recognition of different TLRs by microbial products. As mentioned above, it is possible that, as in Drosophila, different TLRs may recognize different pathogens. It has been shown that peptidoglycan and lipoteichoic acid, both important determinants of the innate response to gram-positive bacteria, also appear to signal via TLR-2 (Schwander et al., 1999). This indicates that TLR-2 may not be specific for LPS. It has also been shown that TLR-2 shows different sensitivities to LPS from different bacteria, possibly pointing to specificity in the response (Yang et al., 1998). Finally, it has been shown that TLR-2 internalizes in response to products from gram-positive bacteria and yeast, and is recruited to the phagosome during phagocytosis. This study also demonstrates that TLR-2 does not respond to LPS, which requires TLR-4, which in turn is unresponsive to gram-positive products (Underhill et al., 1999). It would appear, therefore, that a consensus is emerging whereby it is TLR-4

IL-1 Receptor Family 1581 which is required for responses to LPS, with TLR-2 mediating the response to products from grampositive bacteria and yeast. Intern-alization would also appear to be critical for their effects. This area is likely to be most fruitful for our understanding of host defense against microbial pathogens.

TLR signaling With regard to signaling, given the presence of the TIR domain it was expected that TLRs would signal in the same way as IL-1R. This indeed appears to be the case with TLR-2 and TLR-4 utilizing MyD88, IRAK, IRAK-2, and TRAF-6 in the pathway to NFB (Muzio et al., 1998; Yang et al., 1999; Zhang et al., 1999). It can therefore be concluded that IL-1, IL-18, and LPS all use the same signaling components in their mechanism of action, as shown in Figure 4. Early studies with TLR-1 (then called rsc786) revealed that a chimera between extracellular IL1RI and intracellular TLR-1 was unable to signal, at least in terms of activation of the IL-8 promoter (Mitcham et al., 1996), possibly indicating that there may be different signaling roles for different TLRs. The area of TLRs has therefore opened up new avenues of research which are likely to yield important results for our understanding of immunity and inflammation.

PLANT MEMBERS OF THE FAMILY The IL-1R/TLR family also has plant members. In 1994 the tobacco mosaic virus resistance gene N was cloned from tobacco and, intriguingly, was found to be homologous to IL-1RI and Toll (Whitham et al., 1994). N protein was found to be more related to Toll in that, along with the TIR domain, it also had four leucine-rich repeats. The role of N protein in tobacco is to activate a hypersensitive response in the plant during infection, which leads to necrosis of infected plant tissue, thereby halting pathogen growth and spread. The observation that it contained a TIR domain indicated that this family of proteins is likely to be very ancient, arising in the common unicellular ancestor to plants and animals, if not before, and having a role in defense. It is also likely that the Toll subgroup of the family arose first, with immunoglobulin domains replacing leucine-rich repeats in the IL-1RI subgroup at a later stage. Subsequently several other plant proteins involved in disease resistance were described, including L6 in flax and Rpp5 in Arabidopsis (Hammond-Kosack and Jones, 1996;

Parker et al., 1997). As more genome information is emerging from plant DNA sequencing, this is the fastest-growing group in the family. The ligands for the plant receptors are wholly unknown. Since they are exclusively cytosolic, the ligands must also be cytosolic and could conceivably be derived from intracellular infectious agents. Apart from receptors, disease resistance in plants also involves homologs of IRAK. These include pto and fen in tomato (Jia et al., 1997). This implies that signaling components are also conserved between species, further emphasizing the evolutionary conservation of this system. In terms of downstream consequences NFB family members have yet to be described in plants, although p38 MAP kinases are strongly conserved in all species examined (Caffrey et al., 1999), implying that, similar to IRAK, pto and the other plant homologs may be involved in p38 activation. The conclusion one can draw at this stage is that the IL-1/TLR receptor system and certain of the signaling proteins activated by it are pangenomic.

MYD88 The final member of the family, MyD88, like the plant members, is exclusively cytosolic but, unlike the plant members, the homology is only apparent in the TIR domain: It lacks immunoglobulin domains and leucine-rich repeats. MyD88 was first cloned as an IL-6-inducible protein expressed during myeloid differentiation, which had no known function (Lord et al., 1990). Subsequently, its C-terminal domain was shown to be homologous to Toll, its N-terminus intriguingly containing a death domain (Burns et al., 1998), implying that some of the protein±protein interactions in IL-1 signaling may be similar to those in signaling by the TNF receptor family. IRAK is also purported to have a death domain. Based on these structural features, experiments were performed to determine whether MyD88 would dimerize (Burns et al., 1998). This was shown to be the case, via both the death domains and the TIR domains. In addition it was shown that MyD88 coprecipitates with the IL-1 receptor complex, but only when IL-1RI was liganded, implying that IL-1RI/IL-1R AcP acts to recruit MyD88 to the complex (Wesche et al., 1997a; Burns et al., 1998). Subsequent experiments clearly indicated that MyD88 then recruits IRAK to the complex, MyD88 therefore acting in an analogous manner to TRADD in TNF signaling and Tube in Toll signaling (Muzio et al., 1997; Wesche et al., 1997a; Burns et al., 1998). The simplest scenario is therefore for MyD88 to be the adapter for

1582 Luke A. J. O'Neill and Steve K. Dower recruitment of both IRAKs. As stated above and as shown in Figure 4, the importance of MyD88 in IL-1 and IL-18 signaling can be seen in the MyD88 knockout mouse, which is unable to respond to either cytokine (Adachi et al., 1998). Further studies have shown that in vivo, these mice are unresponsive to LPS (Kawai et al., 1999). In vitro, however, LPS still activates NFB and JNK, although these responses are delayed. This implies that MyD88 is critical for in vivo responses to LPS, but that another adapter may compensate in the cells examined in culture.

CONCLUSIONS AND PERSPECTIVES With increasing information emerging from DNA sequencing, it is clear that the IL-1R/TLR family, and some of the signaling proteins used by the family, is growing rapidly. The role of the family at this stage appears to be in host defense and response to injury, with family members providing the receptors for the key cytokines IL-1 and IL-18, and important pathogen-derived factors such as LPS. The remarkable conservation across species, both in receptors and signaling components, points to the efficiency of this system as a rapid responder to infection and injury, which probably arose in early eukaryotes if not prokaryotes. A number of questions can be posed at this stage. These include: 1. What are the ligands for the orphan receptors in the family? Finding the ligand for ST2 would be an important goal for understanding the control of TH2 cells. Similarly, determining the ligands for TLR family members would be of great use in efforts to understand host±pathogen interactions and also in the area of adjuvants. 2. Are there other family members yet to be described? It is distinctly possible that many more receptors will be described, particularly in plants, whose ligands will be novel cytokines or molecules from pathogens. 3. IL-1RI and IL-1R AcP, IL-18R and AcPL are not necessarily coexpressed in all tissues, indicating that other receptors for IL-1 and IL-18 may exist. This may be particularly relevant in brain, where such coexpression is particularly absent. 4. Are there other MyD88-like molecules, some of which might be inhibitory in an analogous way to the recently described suppressor of death domains proteins?

Future work into this receptor family will yield much information, not only on the molecular basis to aspects of immunity and inflammation, but also on the evolution of the inflammatory and immune responses.

References Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., and Akira, S. (1998). Targetted disruption of the MyD88 gene results in loss of IL-1 and IL-18mediated function. Immunity 9, 143±150. Alcami, A., and Smith, G. L. (1992). A soluble receptor for interleukin-1beta encoded by Vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153±162. Alcami, A., and Smith, G. L. (1996). A mechanism for the inhibition of fever by a virus. Proc. Natl Acad. Sci. USA 93, 11029±11034. Bazan, J. F., Timmins, J. C., and Kastelein, R. A. (1996). A newly defined interleukin-1? Nature 379, 591±592. Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P., and Busslinger, M. (1994). Alternative promoter usage of the Fosresponsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13, 1176±1188. Bird, T. A., and Saklatvala, J. (1986). Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells. Nature 324, 263±266. Bird, T. A., and Saklatvala, J. (1987). Studies on the fate of receptor-bound 125I-interleukin 1 beta in porcine synovial fibroblasts. J. Immunol. 139, 92±97. Born, T. L., Thomassen, E., Bird, T. A., and Sims, J. E. (1998). Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273, 29445±29450. Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., Watt, I., Williams, B., Aitchison, R., McCabe, D., and Musikic, P. (1998). Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthr. Rheum. 41, 2196±2204. Burns, K., Martinon, F., Esslinger, C., Pahl, H., Schneider, P., Bodmer, J. L., Di Marco, F., French, L., and Tschopp, J. (1998). MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273, 12203±12209. Caffrey, D., O'Neill, L. A. J., and Shields, D. (1999). Evidence for co-duplication in MAP kinase pathways in multiple species. J. Mol. Evol. 49, 567±582. Cao, Z., Henzel, W. J., and Gao, X. (1996). IRAK: a kinase association with the interleukin-1 receptor. Science 271, 1128±1131. Carrie, A., Jun, L., Bienvenu, T., Vinet, M. C., McDonell, N., Couvert, P., Zemni, R., Cardona, A., Van Buggenhout, G., Frints, S., Hamel, B., Moraine, C., Ropers, H. H., Strom, T., Howell, G. R., Whittaker, A., Ross, M. T., Kahn, A., Fryns, J. P., Beldjord, C., Marynen, P., and Chelly, J. (1999). A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nature Genet. 23, 25±31. Chan, V., Mecklenbrauker, I., Su, I., Texido, G., Leitges, M., Carsetti, R., Lowell, C. A., Rajewsky, K., Miyake, K., and Tarahovsky, A. (1998). The molecular mechanism of B cell activation by toll-like receptor RP105. J. Exp. Med. 188, 93±101.

IL-1 Receptor Family 1583 Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., and Gusovsky, F. (1999). Toll-like receptor-4 mediates LPS-induced signal transduction. J. Biol. Chem. 274, 10689±10692. Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., and Mantovani, A. (1993). Interleukin 1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261, 472±475. Curtis, B. M., Gallis, B., Overell, R. W., McMahan, C. J., DeRoos, P., Ireland, R., Eisenman, J., Dower, S. K., and Sims, J. E. (1989). T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1. Proc. Natl Acad. Sci. USA 86, 3045±3049. Dinarello, C. A. (1996). Biologic basis for interleukin-1 in disease. Blood 87, 2095±2147. Dower, S. K., Kronheim, S. R., Hopp, T. P., Cantrell, M., Deeley, M., Gillis, S., Henney, C. S., and Urdal, D. L. (1986a). The cell surface receptors for interleukin-1 and interleukin-1 are identical. Nature 324, 266±270. Dower, S. K., Call, S. M., Gillis, S., and Urdal, D. L. (1986b). Similarities between the interleukin-1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc. Natl Acad. Sci. USA 83, 1060±1066. Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., and Thompson, R. C. (1990). Primary structure and functional expression from complimentary DNA of a human interleukin-1 receptor antagonist. Nature 343, 341±343. Eldon, E., Kooyer, S., D'Evelyn, D., Duman, M., Lawinger, P., Botas, J., and Bellen, H. (1994). The Drosophila 18-Wheeler is required for morphogenesis and has striking similarities to Toll. Development 120, 885±895. Gay, N. J., and Keith, F. (1991). Drosophila Toll and IL-1 receptor. Nature 351, 355±356. Gayle, M. A., Slack, J., Bonnert, T., Renshaw, B. R., Sonoda, G., Taguchi, T., Testa, J. R., Dower, S. K., and Sims, J. E. (1996). Cloning of a putative ligand for the T1/ST2 receptor. J. Biol. Chem. 271, 5784±5789. Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K., and Raetz, C. R. (1991). Lipid A-like molecules that antagonise the effects of endotoxin on human monocytes. J. Biol. Chem. 266, 19490±19497. Greenfeeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., and Ju, G. (1995). Molecular cloning and characterisation of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270, 13757±13765. Hammond-Kosack, K. E., and Jones, J. D. (1996). Resistance gene-dependent plant defense responses. Plant Cell. 8, 773±791. Hashimoto, C., Hudson, K. L., and Anderson, K. V. (1988). Cell 52, 269±279. Heguy, A., Baldari, C. T., Macchia, G., Telford, J. L., and Melli, M. (1992). Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila Toll protein are essential for IL-1R signal transduction. J. Biol. Chem. 267, 2605±2609. Heine, H., Kirschning, C. J., Lien, E., Monks, B. G., Rothe, M., and Golenbock, D. T. (1999). Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J. Immunol. 162, 6971±6975. Horuk, R., Huang, J. J., Covington, M., and Newton, R. C. (1987). A biochemical and kinetic analysis of the interleukin-1 receptor: evidence for differences in the molecular properties of IL-1 receptors. J. Biol. Chem. 262, 16275±16282. Hoshino, K., Tsutsui, H., Kawai, T., Takeda, K., Nakanishi, K., Takeda, Y., and Akira, S. (1999a). Generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor related protein as an essential IL-18 binding receptor. J. Immunol. 162, 5041±5044.

Hoshino, K., Kashiwmura, S., Kuribayashi, K., Kodama, T., Tsujimura, T., Nakanishi, K., Matsuyama, T., Takeda, K., and Akira, S. (1999b). The absence of interleukin-1 receptorrelated T1/ST2 does not affact T helper cell type 2 development and its effector function. J. Exp. Med. 190, 1541±1547. Huang, J., Gao, X., Li, S., and Cao, Z. (1997). Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl Acad. Sci. USA 94, 12829±12832. Jia, Y., Loh, Y. T., Zhou, J., and Martin, G. B. (1997). Alleles of pto and fen occur in bacterial speck-susceptible and fenthioninsensitive tomato cultivars and encode active protein kinases. Plant Cell 9, 61±73. Kanakaraj, P., Ngo, K., Wu, Y., Angulo, A., Ghazal, P., Harris, C. A., Siekierka, J. J., Peterson, P. A., and FungLeung, W. P. (1999). Defective IL-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase deficient mice. J. Exp. Med. 189, 1129±1138. Keith, F. J., and Gay, N. J. (1990). The Drosophila membrane receptor Toll can function to promoter cellular adhesion. EMBO J. 9, 4299±4396. Kirschning, C. J., Wesche, H., Ayres, T. M., and Rothe, M. (1998). Human Toll-like receptor 2 confers responsiveness to lipopolysaccharide. J. Exp. Med. 188, 2091±2097. Klemenz, R., Hoffmann, S., and Werenskiold, A. K. (1989). Serum and oncoprotein mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc. Natl Acad. Sci. USA 86, 5708±5712. Kojima, H., Takeuchi, M., Ohta, T., Nishida, Y., Arai, N., Ikeda, M., Ikegami, H., and Kurimoto, M. (1998). Interleukin-18 activates IRAK-TRAF-6 pathway in mouse EL-4 cells. Biochem. Biophys. Res. Commun. 244, 183±186. Kumar, S., Tzimas, M. N., Griswold, D. E., and Young, P. R. (1997). Expression of ST2, an interleukin-1 receptor homolog, is induced by proinflammatory stimuli. Biochem. Biophys. Res. Commun. 235, 474±478. Labow, M., Shuster, D., Zetterstrom, M., Nunes, P., Terry, R., Cullinan, E. B., Bartfai, T., Solorzano, C., Moldawer, L. L., Chizzonite, R., and McIntyre, K. W. (1997). Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159, 2452±2461. Lang, D., Knop, J., Wesche, H., Raffetseder, U., Kurrle, R., Boraschi, D., and Martin, M. U. (1998). The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161, 6871±6877. Lemaitre, B., Reichart, J. M., and Hoffmann, J. A. (1997). Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc. Natl Acad. Sci. USA 94, 14614±14619. Liu, C., Chalmers, D., Maki, R., and De Souza, E. B. (1996). Rat homolog of mouse interleukin-1 receptor accessory protein:cloning, localization and modulation studies. J. Neuroimmunol. 66, 41±48. Lohning, M., Stroemann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J. C., Levinson, D., Radbruch, A., and Kamradt, T. (1998). T1/ST2 is preferentially expressed on murine TH2 cells, independent of interleukin 4, interleukin 5 and interleukin 10, and important for TH2 effector function. Proc. Natl Acad. Sci. USA 95, 6930±6935. Lord, K. A., Hoffman-Liebermann, B., and Liebermann, D. A. (1990). Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5, 1095±1097.

1584 Luke A. J. O'Neill and Steve K. Dower Lovenberg, T. W., Crowe, P. D., Liu, C., Chalmers, D. T., Liu, X. J., Liaw, C., Clevenger, W., Oltersdorf, T., De Souza, E. B., and Maki, R. A. (1996). Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1Rrp2). J. Neuroimmunol. 70, 113±122. McMahon, C. J., Slack, J. L., Mosely, B., Cosman, D., Lupton, S. D., Brunton, L. L., Grubin, C. E., Wignall, J. M., Jenkins, N. A., Brannan, C. I., Copeland, N. G., Huebner, K., Croce, C. M., Cannizzaro, L. A., Benjamin, D., Dower, S. K., Spriggs, M. G., and Sims, J. E. (1991). A novel IL-1 receptor cloned from B cells by mammalian expression is expressed in many cell types. EMBO J. 10, 2821±2832. Marmiroli, S., Bavelloni, A., Faenza, I., Sirri, A., Ognibene, A., Cenni, V., Tsukada, J., Koyama, Y., Ruzzene, M., Ferri, A., Auron, P. E., Toker, A., and Maraldi, N. M. (1998). Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. FEBS Lett. 438, 49±54. Martin, M., Bol, G. F., Eriksson, A., Resch, K., and BrigeliusFlohe, R. (1994). Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cell. Eur. J. Immunol. 24, 1566±1571. Matsushima, K., Akahoshi, T., Yamada, M., Furutani, Y., and Oppenheim, J. J. (1986). Properties of specific IL-1 receptor on human Epstein Barr-transformed B lymphocytes: identity of the receptors for IL-1alpha and IL-1beta. J. Immunol. 136, 4496±4503. Medzhitov, R., Preston-Hurlburt, P., and Janeway, C. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394±397. Meng, X., Khanuja, B. S., and Ip, Y. T. (1999). Toll receptormediated Drosophila immune response requires Dif, an NF-kappaB factor. Genes Dev. 13, 792±797. Mitcham, J. L., Parnet, P., Bonnert, T., Garka, K., Gerhart, M. J., Slack, J., Gayle, M. A., Dower, S. K., and Sims, J. E. (1996). T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J. Biol. Chem. 271, 5777±5783. Miyake, K., Yamashita, M., Ogata, T., and Kimoto, M. (1995). RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 3333±3340. Mizuguchi, K., Parker, J. S., Blundell, T. L., and Gay, N. J. (1998). Getting knotted: a model for the structure and activation of Spatzle. Trends Biochem. Sci. 23, 239±242. Morisato, D., and Anderson, K. V. (1994). The spatzle gene encodes a component of the extracellular signaling pathway establishing the dorsal±ventral pattern in the Drosophila embryo. Cell 76, 677±684. Muzio, M., Ni, J., Feng, P., and Dixit, V. M. (1997). IRAK (pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612±1615. Muzio, M., Natoli, G., Saccani, S., Levrero, M., and Mantovani, A. (1998). The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187, 2097±2101. O'Neill, L. A. J., and Greene, C. (1998). Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects and plants. J. Leuk. Biol. 63, 650±657. Parker, J. E., Coleman, M. J., Szabo, V., Frost, L. N., Schmidt, R., van der Biezen, E. A., Moores, T., Dean, C., Daniels, M. J., and Jones, J. D. (1997). The arabidopsis downy mildew resistance gene RPP5 shares similarity to the toll and interleukin-1 receptors with N and L6. Plant Cell 9, 879±894. Parnet, P., Garka, K. E., Bonnert, T. E., Dower, S. K., and Sims, J. E. (1996). IL-1RrP is a novel receptor-like molecule

similar to the type I interleukin-1 receptor and its homologs T1/ST2 and IL-1RAcP. J. Biol. Chem. 271, 3967±3970. Poltorak, A., He, X., Smirnova, I., Lie, M. Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998). Defective LPS signaling in CSH/HeJ and C57BL/10ScCr mice: mutations in TLR-4 gene. Science 282, 2085±2088. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., and O'Garra, A. (1997). IGIF does not drive TH1 development but synergises with IL-12 for interferon gamma production and activated IRAK and NF-kappaB. Immunity 7, 571±581. Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., and Bazan, F. (1998). A family of human receptors structurally related to Drosophila Toll. Proc. Natl Acad. Sci. USA 95, 588±593. Schreuder, H., Tarfif, C., Trump-Kallmeyer, S., Soffientini, A., Sarubbi, E., Akeson, A., Bowlin, T., Yanofsky, S., and Barrett, R. W. (1997). A new cytokine receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386, 194±200. Schwander, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. J. (1999). Peptidoglycan and lipoteichoic acidinduced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274, 17406±17409. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., and Kimoto, M. (1999). MD-2, a molecule that confers lipopolysaccharaide responsiveness on toll-like receptor 4. J. Exp. Med. 189, 1777±1782. Shinkura, R., Kitada, K., Matsuda, F., Tashiro, K., Ikuta, K., Suzuki, M., Kogishi, K., Serikawa, T., and Honjo, T. (1999). Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa B-inducing kinase. Nature Genet. 22, 74±77. Sims, J. E., and Dower, S. K. (1994). Interleukin-1 receptors. Eur. Cytok. Netw. 5, 539±546. Sims, J. E., March, C. J., Cosman, D., Widmer, M. B., MacDonald, H. R., MacMahon, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., Friend, D., Alpert, A. R., Gillis, S., Urdal, D. L., and Dower, S. K. (1988). cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241, 585±589. Sims, J. E., Gayle, M. A., Slack, J. L., Alderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Mantovani, A., Shanebeck, K., Grabstein, K. H., and Dower, S. K. (1993). Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl Acad. Sci. USA 90, 6155±6161. Sizemore, N., Leung, S., and Stark, G. R. (1999). Activation of phosphatidlyinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell Biol. 19, 4798±4805. Spriggs, M. K., Hruby, D. E., Maliszewski, C. R., Pickup, D. J., Sims, J. E., Buller, R. M. L., and Van Slyke, J. (1992). Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell 71, 145±153. Stylianou, E., O'Neill, L. A. J., Edbrooke, M. R.., Woo, P., and Saklatvala, J. (1992). Interleukin-1 induces NFB through its type I and not type II receptor. J. Biol. Chem. 270, 13757± 13765. Symons, J. A., Young, P. R., and Duff, G. W. (1995). Soluble type II IL-1 receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc. Natl Acad. Sci. USA 92, 1714±1718. Takeuchi, O., Kawai, T., Sanjo, H., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Takeda, K., and Akira, S.

IL-1 Receptor Family 1585 (1999). TLR-6: a novel member of an expanding toll-like receptor family. Gene 29, 59±65. Thomassen, E., Renshaw, B. R., and Sims, J. E. (1999). Identification and characterisation of SIGIRR, a molecule representing a novel sub-type of the IL-1R superfamily. Cytokine 11, 389±399. Tominaga, S. (1989). A putative protein of a growth specific cDNA from BALB/c 3T3 cells is highly similar to the extracellular portion of mouse interleukin-1 receptor. FEBS Lett. 258, 301±304. Torigoe, K., Ushio, S., Okura, T., Kobayashi, S., Taniai, M., Kunikata, T., Murakami, T., Sanou, O., Kojima, H., Fugii, M., Ohta, T., Ikeda, M., Ikegami, H., and Kurimoto, M. (1997). Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272, 25737±25742. Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E., and McKenzie, A. N. J. (2000). T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing promary T helper cell type 2 responses. J. Exp. Med. 191, 1069±1075. Underhill, D. M., Ozinsky, A., Hajjar, A. M., Stevens, A., Wilson, C. B., Bassetti, M., and Aderam, A. (1999). The Tolllike receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811±815. Vigers, G. P., Anderson, L. J., Caffes, P., and Brandhuber, B. J. (1997). Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature 386, 190±194. Volpe, F., Clatworthy. J., Kaptein, A., Maschera, B., Griffin, A. M., and Ray, K. (1997). The IL-1 receptor accessory protein is responsible for the recruitment of the interleukin-1 receptor associated kinase to the IL1/IL1 receptor I complex. FEBS Lett. 419, 41±44. Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S., and Cao, Z. (1997a). MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837±847. Wesche, H., Korherr, C., Kracht, M., Falk, W., Resch, K., and Martin, M. U. (1997b). The interleukin-1 receptor accessory protein in essential for IL-1-induced activation of interleukin-1 receptor associated kinase and stress-activated protein kinases. J. Biol. Chem. 272, 7727±7731. Wesche, H., Gao, X., Li, X., Kirschning, C. J., Stark, G. R., and Cao, Z. (1999). IRAK-M is a novel member of the

pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274, 19403±19410. Whitham, S., Dinesh-Kumar, S. P., Choi, D., Hehl, R., Corr, C., and Baker, B. (1994). The product of the tobacco mosaic virus resistence gene N: similarity to Toll and the interleukin-1 receptor. Cell 78, 1101±1115. Williams, M. J., Rodriguez, A., Kimbrell, D. A., and Eldon, E. D. (1998). The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 16, 6120±6130. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. (1990). CD14, a receptor for complexes of LPS and LPS binding protein. Science 249, 1431±1434. Xu, D., Chan, W. L., Leung, B. P., Hunter, D., Schulz, K., Carter, R. W., McInnes, I. B., Robinson, J. H., and Liew, F. Y. (1998). Selective expression and functions of interleukin 18 receptor on T helper type 1 but not TH2 cells. J. Exp. Med. 188, 1485±1492. Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T., and Tominaga, S. (1993). Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 318, 83±87. Yang, R. B., Mark, M. R., Gray, A., Huang, A., Xie, M. H., Zhang, M., Goddard, A., Wood, W. I., Gurney, A. L., and Godowski, P. J. (1998). Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 395, 284±288. Yang, R. B., Mark, M. R., Gurney, A. L., and Godowski, P. J. (1999). Signaling events induced by lipopolysaccharideactivated toll-like receptor 2. J. Immunol. 163, 639±643. Yoon, D. Y., and Dinarello, C. A. (1998). Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J. Immunol. 160, 3170± 3179. Zhang, F. X., Kirschning, C. J., Mancinelli, R., Xu, X. P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M., and Arditi, M. (1999). Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274, 7611±7614.